search
NASDAQ:VRDN
USD
12.29
- (2.2%)
VIRIDIAN THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 7 May 2025 GMT-4
USD 12.29
- (2.2%)
End of Day: 7 May 2025 GMT-4
Industry: Biotechnology

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candid...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices